DSM venture capital arm, pharma giant Novo back alternative feed ingredient producer

The company's product will be trialed by aquafeed manufacturer BioMar.

Peter Rowe, CEO of fledgling UK biotech company Deep Branch. — Peter Rowe, CEO of fledgling UK biotech company Deep Branch.Photo: Deep Branch

Demi Korban

Published 16 March 2021, 12:33Updated 16 March 2021, 12:41

Alternative feed BioMar Venture Capital DSM Carbon emissions